BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 24944652)

  • 1. Oncotargets GD2 and GD3 are highly expressed in sarcomas of children, adolescents, and young adults.
    Dobrenkov K; Ostrovnaya I; Gu J; Cheung IY; Cheung NK
    Pediatr Blood Cancer; 2016 Oct; 63(10):1780-5. PubMed ID: 27304202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimization of rhabdomyosarcoma disseminated disease assessment by flow cytometry.
    Almazán-Moga A; Roma J; Molist C; Vidal I; Jubierre L; Soriano A; Segura MF; Llort A; Sánchez de Toledo J; Gallego S
    Cytometry A; 2014 Dec; 85(12):1020-9. PubMed ID: 25155056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autologous haematopoietic stem cell transplantation following high-dose chemotherapy for non-rhabdomyosarcoma soft tissue sarcomas: a Cochrane systematic review*.
    Peinemann F; Labeit AM
    BMJ Open; 2014 Jul; 4(7):e005033. PubMed ID: 25079925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorescence and antioxidant activity of heterologous expression of phycocyanin and allophycocyanin from
    Shang MH; Sun JF; Bi Y; Xu XT; Zang XN
    Front Nutr; 2023; 10():1127422. PubMed ID: 36891162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow Cytometry Immunophenotyping for Diagnostic Orientation and Classification of Pediatric Cancer Based on the EuroFlow Solid Tumor Orientation Tube (STOT).
    Ferreira-Facio CS; Botafogo V; Ferrão PM; Canellas MC; Milito CB; Romano S; Lopes DV; Teixeira LC; Oliveira E; Bruno-Riscarolli E; Mello FV; Siqueira PFR; Moura P; Macedo FN; Forny DN; Simião L; Pureza AL; Land MGP; Pedreira CE; Dongen JJMV; Orfao A; Costa ESD
    Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy.
    Bruni D; Angell HK; Galon J
    Nat Rev Cancer; 2020 Nov; 20(11):662-680. PubMed ID: 32753728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multivariate analysis of risk factors for patients with stage 4 neuroblastoma who were older than 18 months at diagnosis: a report from a single institute in Shanghai, China.
    Cai J; Pan C; Tang Y; Chen J; Zhou M; Li B; Xue H; Shen S; Gao Y; Zhang A; Tang J
    J Cancer Res Clin Oncol; 2017 Jul; 143(7):1327-1335. PubMed ID: 28283783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Childhood rhabdomyosarcoma metastatic to bone marrow presenting with disseminated intravascular coagulation and acute tumour lysis syndrome: review of the literature apropos of two cases.
    Bien E; Maciejka-Kapuscinska L; Niedzwiecki M; Stefanowicz J; Szolkiewicz A; Krawczyk M; Maldyk J; Izycka-Swieszewska E; Tokarska B; Balcerska A
    Clin Exp Metastasis; 2010 Aug; 27(6):399-407. PubMed ID: 20517638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nasal embryonal rhabdomyosarcoma with bone marrow metastasis simulating acute leukemia: A case report and review of the literature.
    Nazco Deroy Á; Martín Batista S; Álvarez-Argüelles Cabrera H; García Hernández S; Raya Sánchez JM
    Rev Esp Patol; 2019; 52(2):87-91. PubMed ID: 30902383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Staging and monitoring of childhood rhabdomyosarcoma with flow cytometry.
    Shen H; Tang Y; Dong A; Li H; Shen D; Yang S; Tang H; Gu W; Shu Q
    Oncol Lett; 2014 Apr; 7(4):970-976. PubMed ID: 24944652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flow cytometric phenotype of rhabdomyosarcoma bone marrow metastatic cells and its implication in differential diagnosis with neuroblastoma.
    Bozzi F; Collini P; Aiello A; Barzanò E; Gambirasio F; Podda M; Meazza C; Ferrari A; Luksch R
    Anticancer Res; 2008; 28(3A):1565-9. PubMed ID: 18630512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of micrometastasis of neuroblastoma to bone marrow and tumor dissemination to hematopoietic autografts using flow cytometry and reverse transcriptase-polymerase chain reaction.
    Tsang KS; Li CK; Tsoi WC; Leung Y; Shing MM; Chik KW; Lee V; Ng MH; Yuen P
    Cancer; 2003 Jun; 97(11):2887-97. PubMed ID: 12767104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interference of bone marrow CD56
    Theodorakos I; Paterakis G; Papadakis V; Vicha A; Topakas G; Jencova P; Karchilaki E; Taparkou A; Tsagarakis NJ; Polychronopoulou S
    Pediatr Blood Cancer; 2019 Aug; 66(8):e27799. PubMed ID: 31066205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimal residual disease is a prognostic marker for neuroblastoma with bone marrow infiltration.
    Cai JY; Pan C; Tang YJ; Chen J; Ye QD; Zhou M; Xue H; Tang JY
    Am J Clin Oncol; 2012 Jun; 35(3):275-8. PubMed ID: 21537148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flow cytometry and fluorescence in situ hybridization to detect residual neuroblastoma cells in bone marrow.
    Okcu MF; Wang RY; Bueso-Ramos C; Schober W; Weidner D; Andrassy R; Blakely M; Russell H; Ozkan A; Kuttesch J; Andreeff M; Chan KW; Ater J
    Pediatr Blood Cancer; 2005 Nov; 45(6):787-95. PubMed ID: 15929127
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.